Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout. Kang EH, Park EH, Shin A, Song JS, et al. Eur Heart J 2021 Sep 11. pii: 6368678. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kang EH, Park EH, Shin A, Song JS, et al. Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout. Eur Heart J 2021 Sep 11. pii: 6368678. doi: 10.1093.
PMID: 34508567